Recently, it was shown that in subjects with diabetes, higher omentin concentrations were associated with increased risk for cardiovascular events [49], moreover elevated omentin levels were observed in nonalcoholic fatty liver disease and in inflammatory states [50]. Here, ITLN1 is linked to metabolic dysfunction-associated steatotic liver disease.